Lannett Company announced that its board of directors has named Timothy C. Crew as the company’s chief executive officer, effective January 2, 2018.  The Board of Directors intends to appoint Crew as a director of the company after completion of its 2018 Annual Meeting of Stockholders. 

Crew has more than 25 years of experience in the generic and branded pharmaceutical industries, most recently serving as CEO of Cipla North America, a global pharmaceutical company based in Mumbai, India, from 2013 to 2017.  

“After a thorough and comprehensive search process, we are thrilled and excited to welcome Tim as our CEO,” said Jeffrey Farber, Lannett’s Chairman.  “Tim has served in a variety of senior leadership roles with some of the largest, most recognized and well respected companies in the pharmaceutical industry.  He is an experienced operations executive, with a proven background driving growth, developing new markets and successfully launching both proprietary and generic products..”